HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Xiaoyuan Chen Selected Research

Heterologous Transplantation (Xenotransplantation)

12/2015Quantitative Evaluation of Tumor Early Response to a Vascular-Disrupting Agent with Dynamic PET.
11/201518F-Labeled Single-Stranded DNA Aptamer for PET Imaging of Protein Tyrosine Kinase-7 Expression.
10/2015Ortho-Stabilized (18) F-Azido Click Agents and their Application in PET Imaging with Single-Stranded DNA Aptamers.
1/2015Intrinsically radioactive [64Cu]CuInS/ZnS quantum dots for PET and optical imaging: improved radiochemical stability and controllable Cerenkov luminescence.
12/2014PET and NIR optical imaging using self-illuminating (64)Cu-doped chelator-free gold nanoclusters.
8/2014Chelator-free (64)Cu-integrated gold nanomaterials for positron emission tomography imaging guided photothermal cancer therapy.
7/2014In Vivo Labeling of Serum Albumin for PET.
5/2014Targeted therapeutic nanotubes influence the viscoelasticity of cancer cells to overcome drug resistance.
2/2014Self-illuminating 64Cu-doped CdSe/ZnS nanocrystals for in vivo tumor imaging.
12/2013Comparison of (18)F-labeled CXCR4 antagonist peptides for PET imaging of CXCR4 expression.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Xiaoyuan Chen Research Topics

Disease

256Neoplasms (Cancer)
12/2015 - 01/2004
25Breast Neoplasms (Breast Cancer)
03/2014 - 01/2004
24Glioblastoma (Glioblastoma Multiforme)
12/2014 - 04/2004
22Neoplasm Metastasis (Metastasis)
04/2015 - 01/2004
17Glioma (Gliomas)
01/2015 - 02/2004
9Prostatic Neoplasms (Prostate Cancer)
10/2013 - 08/2004
9Brain Neoplasms (Brain Tumor)
04/2010 - 01/2004
7Inflammation
10/2014 - 11/2007
5Brain Injuries (Brain Injury)
07/2015 - 01/2012
5Insulinoma
11/2014 - 10/2011
4Colonic Neoplasms (Colon Cancer)
10/2015 - 06/2008
4Stroke (Strokes)
10/2014 - 01/2008
4Ischemia
04/2014 - 01/2007
4Ovarian Neoplasms (Ovarian Cancer)
01/2014 - 09/2009
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2013 - 07/2009
4Colorectal Neoplasms (Colorectal Cancer)
11/2011 - 02/2007
4Melanoma (Melanoma, Malignant)
10/2011 - 05/2007
3Lung Neoplasms (Lung Cancer)
12/2015 - 03/2005
3Carcinoma (Carcinomatosis)
11/2015 - 09/2004
3Myocardial Infarction
01/2015 - 01/2007
3Anoxia (Hypoxia)
06/2011 - 09/2008
2Body Weight (Weight, Body)
02/2015 - 01/2014

Drug/Important Bio-Agent (IBA)

43Integrin alphaVbeta3IBA
02/2010 - 01/2004
42arginyl-glycyl-aspartic acidIBA
08/2014 - 01/2004
33PeptidesIBA
10/2015 - 09/2004
19Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2012 - 11/2006
17cyclic arginine-glycine-aspartic acid peptideIBA
09/2012 - 01/2004
13BombesinIBA
10/2013 - 08/2004
13LuciferasesIBA
06/2013 - 11/2006
12Doxorubicin (Adriamycin)FDA LinkGeneric
05/2015 - 01/2009
12ferric oxide (iron oxide)IBA
05/2013 - 08/2008
12IntegrinsIBA
01/2013 - 01/2004
111,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
12/2015 - 05/2008
11GoldIBA
09/2015 - 04/2011
11Bombesin Receptors (Bombesin Receptor)IBA
10/2013 - 03/2006
10Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
12/2012 - 11/2006
10Integrin alphaVIBA
05/2008 - 01/2004
9Glycine (Aminoacetic Acid)FDA LinkGeneric
08/2014 - 03/2005
9Arginine (L-Arginine)FDA Link
08/2014 - 03/2005
9Small Interfering RNA (siRNA)IBA
08/2014 - 09/2006
8Contrast MediaIBA
12/2014 - 11/2004
8Matrix MetalloproteinasesIBA
11/2014 - 01/2011
8Carbon Nanotubes (Carbon Nanotube)IBA
05/2014 - 08/2008
8Glucose (Dextrose)FDA LinkGeneric
03/2014 - 05/2006
7Aspartic Acid (Aspartate)FDA Link
08/2014 - 03/2005
7Carbon MonoxideIBA
01/2014 - 01/2007
7LigandsIBA
10/2012 - 03/2005
7Epidermal Growth Factor Receptor (EGF Receptor)IBA
03/2011 - 06/2007
6GraphiteIBA
09/2015 - 10/2012
6Ferritins (Ferritin)IBA
10/2014 - 02/2011
6Hyaluronic Acid (Hyaluronan)IBA
08/2014 - 01/2012
6Biological Markers (Surrogate Marker)IBA
06/2014 - 01/2008
5exenatide (Byetta)FDA Link
01/2015 - 01/2012
5Glucagon-Like Peptide 1 (GLP 1)IBA
01/2015 - 10/2011
5CY5.5 cyanine dyeIBA
12/2014 - 05/2006
5Paclitaxel (Taxol)FDA LinkGeneric
01/2014 - 02/2005
5tricineIBA
10/2013 - 03/2007
5AntibodiesIBA
07/2012 - 12/2005
5Molecular Probes (Molecular Probe)IBA
04/2012 - 05/2007
5CationsIBA
08/2011 - 10/2007
5Cell Adhesion MoleculesIBA
01/2011 - 01/2004
4Serum AlbuminIBA
10/2015 - 03/2009
4Silicon Dioxide (Sand)FDA LinkGeneric
04/2015 - 06/2012
41-phenyl-3,3-dimethyltriazene (PDT)IBA
02/2015 - 05/2014
4CXCR4 Receptors (CXCR4 Receptor)IBA
01/2015 - 11/2010
4glucuronyl glucosamine glycan sulfate (Vessel)IBA
06/2014 - 11/2008
4TNF-Related Apoptosis-Inducing LigandIBA
09/2012 - 02/2011
4Fluorescent Dyes (Fluorescent Probes)IBA
08/2010 - 11/2005
4Integrin beta3 (GPIIIa)IBA
04/2009 - 11/2004
3Indocyanine Green (Cardio-Green)FDA LinkGeneric
10/2015 - 11/2010
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
10/2015 - 01/2011
3Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
04/2015 - 10/2004
3MicroRNAs (MicroRNA)IBA
08/2014 - 01/2013
3AntigensIBA
10/2013 - 10/2011
3bombesin (7-14)IBA
10/2013 - 03/2008
3Ethylene Glycol (Monoethylene Glycol)IBA
09/2012 - 02/2010
3Peptide LibraryIBA
11/2011 - 08/2010
3DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
01/2011 - 04/2010
3Cell Surface ReceptorsIBA
01/2011 - 07/2009
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2010 - 11/2007
3cetuximab (Erbitux)FDA Link
04/2010 - 06/2007
3Chelating AgentsIBA
05/2009 - 05/2008
3vitaxinIBA
11/2008 - 09/2006
2Gelonium multiflorum GEL proteinIBA
12/2015 - 03/2007
2Phosphotransferases (Kinase)IBA
11/2015 - 01/2008
2Photosensitizing Agents (Photosensitizers)IBA
04/2015 - 08/2013
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2015 - 04/2008
2glucagon-like peptide receptor (receptor, glucagon-like peptide)IBA
01/2015 - 01/2012

Therapy/Procedure

71Heterologous Transplantation (Xenotransplantation)
12/2015 - 04/2004
17Drug Therapy (Chemotherapy)
11/2015 - 09/2006
12Intravenous Injections
10/2015 - 01/2006
9Photochemotherapy (Photodynamic Therapy)
11/2015 - 08/2013
9Lasers (Laser)
10/2015 - 02/2008
7Aftercare (After-Treatment)
12/2015 - 03/2007
7Quantum Dots (Quantum Dot)
08/2012 - 04/2006
6Therapeutics
05/2014 - 01/2007
3Immunotherapy
11/2015 - 04/2010
3Transplantation (Transplant Recipients)
07/2015 - 10/2008
3Microspheres (Microsphere)
10/2013 - 02/2011
3Radioimmunotherapy
08/2010 - 11/2008